11.7Impact Factor Articles & Issues About Publish Submit search About the journal Cell Reports Medicineis a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine. ...
Read the latest articles of Cell Reports Medicine at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine. The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians ...
Journal Impact Factor: 7.1 5-year Journal Impact Factor: 7.9 Source Normalized Impact per Paper (SNIP): 1.277 SCImago Journal Rank (SJR): 1.798 Speed 2024 Submission to first editorial decision (median days): 16 Submission to acceptance (median days): 126 ...
Different variants of cell culture found application in modeling diseases, IVF technology, stem cell and cancer research, monoclonal antibody production, regenerative medicine and therapeutic protein production. All those different scientific approaches would not be possible without some crucial discoveries ...
Insights into the role of the tumor suppressor pVHL in oxygen sensing motivated the testing of drugs that target the transcription factor HIF or HIF-responsive growth factors, such as VEGF, for the treatment of cancers caused by VHL inactivation, such as
To start with, we provide a free, no-obligation online consultation with regenerative medicine experts. During this consultation, patients receive comprehensive information about the potential benefits of stem cell therapy for their condition, the cost and duration of the therapy, and a personalized tr...
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg. Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany M. Mastel & R. Jackstadt Faculty of Biosciences, Heidelberg Unive...
Read the latest articles of Cell Reports Medicine at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Bromodomain and extraterminal domain (BET) proteins have emerged as therapeutic targets in multiple cancers, including the most common primary adult brain tumor glioblastoma (GBM). Although several BET inhibitors have entered clinical trials, few are bra